Cian Healthcare share news, announcements and annual reports
BSE: 542678Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 28 Oct 2026. Previous close ₹31.57.
28 Oct: open ₹32.20, high ₹32.20, low ₹32.20
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹81 Cr4,297th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 9.43
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- −113.9%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 3.36
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 822
Cian Healthcare share news and announcements
462 announcements, routine notices left out, newest first. Page 3 of 10.
Mar 2025
13 Mar · Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee of Creditors
7 Mar · Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee of Creditors
6 Mar · Corporate Insolvency Resolution Process (CIRP)-Intimation of meeting of Committee of Creditors
Feb 2025
22 Feb · Management
22 Feb · Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee of Creditors
20 Feb · Management
13 Feb · Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee of Creditors
Jan 2025
31 Jan · Announcement under Regulation 30 (LODR)-Change in Registered Office Address
31 Jan · Management
31 Jan · Management
31 Jan · Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee of Creditors
31 Jan · Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee of Creditors
31 Jan · Management
31 Jan · Management
25 Jan · Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee of Creditors
21 Jan · Corporate Insolvency Resolution Process (CIRP)-Intimation of meeting of Committee of Creditors
21 Jan · Management
16 Jan · Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee of Creditors
11 Jan · Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee of Creditors
4 Jan · Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee of Creditors
2 Jan · Management
1 Jan · Corporate Insolvency Resolution Process (CIRP)-Intimation of meeting of Committee of Creditors
1 Jan · Management
Dec 2024
18 Dec · Corporate Insolvency Resolution Process (CIRP)-Updates - Corporate Insolvency Resolution Process (CIRP)
9 Dec · Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee of Creditors
9 Dec · Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee of Creditors
6 Dec · Corporate Insolvency Resolution Process (CIRP)-Intimation of meeting of Committee of Creditors
Nov 2024
13 Nov · Non-Applicability Of Related Party Disclosure Under Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Oct 2024
9 Oct · Meeting
7 Oct · Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee of Creditors
Sep 2024
12 Sep · Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee of Creditors
11 Sep · Corporate Insolvency Resolution Process (CIRP)-List of Creditors
Aug 2024
23 Aug · Announcement under Regulation 30 (LODR)-Change in Corporate Office Address
19 Aug · Corporate Insolvency Resolution Process (CIRP)-Public Announcement
14 Aug · Corporate Insolvency Resolution Process (CIRP)-Admission of application by Tribunal
9 Aug · Intimation About Bank Accounts Of The Company Downgraded To Non Performing Asset (NPA)
Jul 2024
9 Jul · Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015- Penal Action For Non Compliance
9 Jul · Legal
Quarterly Disclosures by listed entities of defaults on payment of interest/ repayment of principal amount on loans from banks / financial institutions and unlisted debt securities4 Jul · Board meeting
Meeting on 12 Jul 2024: increase in authorised capital and preferential issue of shares